CD79A and neoplasm: PD-L1 blockade significantly increased the titres of tumour-binding IgG and IgA class-switched antibodies (Fig. 2i), in line with the reported increase in GC responses and antibody titres in PD-L1-deficient mice following model antigen immunization21.